Skip to main content

GSK2302032A Antigen-Specific cancer Immunotherapeutic as adjuvant therapy in patients with Non-Small Cell Lung Cancer

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

GlaxoSmithKline

Start Date

October 1, 2013

End Date

March 19, 2015
 

Administered By

Duke Cancer Institute

Awarded By

GlaxoSmithKline

Start Date

October 1, 2013

End Date

March 19, 2015